Data protection Impressum

R&D

Cytiva’s recent move underlines Western Switzerland’s Health Valley region's growing significance as a hub for healthcare technology.

Cytiva’s strategic expansion in Western Switzerland’s Health Valley

11 December 2023

Novochizol technology quantitatively transforms single linear chitosan molecules into cross-linked, uniformly sized nanospheres.

EPFL and Novochizol to collaborate on designing more efficient immunotherapies

2 November 2023

Marco Scicolone (to the left) and Alexander Fink (to the right) are looking forward to working together.

Regulatory compliance expert Metecon establishes its Swiss subsidiary in Bern

30 October 2023

Established in the canton of Valais since 1989, Debiopharm is building a full-scale research and innovation campus in Martigny.

Debiopharm invests CHF 30 million in Valais amidst workforce surge

26 October 2023

Western Switzerland's commitment to 3D printing and manufacturing is multi-faceted, bridging research, industry, and academia.

3D printing and manufacturing in Western Switzerland

25 October 2023

Valsynthèse’s name originates from the high-energy value of the chemical reactions involved, necessitating a special skill set for manipulation.

Valsynthèse, 40 years of innovation in the canton of Valais

23 October 2023

The various projects and collaborations underway in Neuchâtel exemplify its commitment to harnessing solar energy for a sustainable future.

Solar technology advancements in the canton of Neuchâtel

18 October 2023

PULSE, with its distinctive amalgamation of adaptable, future-proof infrastructure, is set to become a pivotal hub designed to uplift and expand the frontiers of biotech and various scientific ventures.

PULSE, a modular innovation center in the heart of the Health Valley

10 October 2023

Through this partnership, the synergy between academic excellence and pioneering biotherapeutic research is set to delineate new horizons in patient care, particularly in the field of tissue regeneration and repair.

Orio Therapeutics partners with Australia’s largest University to transform regenerative medicine

10 October 2023

The Institute of Life Technologies of the HES-SO Valais/Wallis has forged a five-year collaboration with Debiopharm Research & Manufacturing to develop new targeted antibody fragment vectorization technologies.

HES-SO Valais-Wallis and Debiopharm partner up to battle cancer

4 October 2023

1 … 7 8 9 10 11 12 13 14 15 … 17